Final_close_process egfr-targeted sirna nanoparticles to treat nsclc

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201300030C
Awardee
Awarding agency
Obligated
$1,199,291

Award facts

Opportunity
Contract value 100% obligated
$1,199,291.47 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 24 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Chaska, MN 55318, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 -$709
Change Order 9 $0
Other Administrative Action 8 $0
Exercise an Option 7 $1,000,000
Other Administrative Action 6 · Egfr-targeted sirna nanoparticles to treat nsclc $0
Other Administrative Action 5 $0
Other Administrative Action 4 $0
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $200,000
Show all 11

Quick answers

Who was awarded contract HHSN261201300030C?

HHSN261201300030C was awarded to Genesegues Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2013.

How much is contract HHSN261201300030C worth?

The government has obligated $1,199,291 on HHSN261201300030C.

Was contract HHSN261201300030C competed?

The extent of competition for HHSN261201300030C was full and open competition after exclusion of sources. The government received 24 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award